Dolutegravir/Lamivudine in Treatment-Naïve Pregnant Women

Clinical trial NCT07616739 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07616739
Sponsor: Fundación Huésped
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

HIV-1-infection

Start date: 2026-06-15
Primary completion: 2028-07-15
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.